Prostate cancer (PC) is the third-leading cause of cancer-related deaths worldwide.
Although the current treatment strategies are progressing rapidly, PC is still representing a …

Background Risk stratification or progression in prostate cancer is performed with the
support of clinical-pathological data such as the sum of the Gleason score and serum levels …

As one of the most important demethylases for RNA N6-methyladenosine (m6A)
modifications, fat mass and obesity-associated protein (FTO) plays anti-cancer role during …

Simple Summary There are diverse reports of the dual role of sirtuin genes and proteins in
breast and prostate cancers. This review discusses the current information on the tumor …

Simple Summary Current diagnostics of prostate cancer often show unsatisfactory results,
leading to delayed detection or overtreatment. Urinary microRNAs are a class of promising …

Abstract Background Prostate cancer (PCa), the second most prevalent solid tumor among
men worldwide, has caused greatly increasing mortality in PCa patients. The effects of lipid …

METTL3 was known to run through the whole cycle of RNA. It relied on m6A modification in
the mRNAs of cancer‐related genes to regulate tumour progression. The development of …

Application of bone marrow-derived mesenchymal stem cell-derived exosomes (BMSC-
exos) in cancer treatment has been widely studied. Here, we elaborated the function of …

Prostate cancer (PCa) is a common malignant tumor of the male genitourinary system that
seriously affects the quality of life of patients. Studying the pathogenesis and therapeutic …

Background Gaining insight into microRNAs (miRNAs) and genes that regulate the
therapeutic response of cancer diseases in general and prostate cancer (PCa) in particular …